In health economics and outcomes research (HEOR) and epidemiologic studies, claims data alone leave researchers without essential information such as: Body mass index (BMI) or weight trajectory to identify obesity thresholds or track improvement A1c and lipid panels to assess cardiometabolic change Liver and kidney markers such as ALT, AST, and eGFR to evaluate comorbidities like MASH or nephropathy Physician notes that document adherence barriers, recommended dosing schedules, or dietary guidance These gaps in claims mean that researchers are missing many aspects of the patient journey (Figure 1)
NSAIDs like ibuprofen can impair renal function, especially in dehydrated states, potentially leading to acute kidney injury
Wegovy is suitable for adults when combined with a low-calorie diet and regular exercise, if you meet one of these criteria: Initial BMI 30 kg/m 2 (clinically obese) Initial BMI 27 kg/m 2 (overweight) with at least one weight-related comorbidity (e.g
The zero-calorie, zero-sugar format makes either version easy to incorporate throughout the day
L., Feldpausch, M
In fact, KLOW often works best when its part of a comprehensive care plan
